Literature DB >> 25384536

Development of a reverse genetics system based on RNA polymerase II for Newcastle disease virus genotype VII.

Jianzhong Wang1, Chunfeng Wang, Na Feng, Hualei Wang, Xuexing Zheng, Songtao Yang, Yuwei Gao, Xianzhu Xia, Renfu Yin, Xiufan Liu, Shunlin Hu, Chan Ding, Shengqing Yu, Yanlong Cong, Zhuang Ding.   

Abstract

Newcastle disease virus (NDV) has only a single serotype but diversified genotypes. Genotype VII strains are the prevalent currently circulating genotype worldwide, and in particular, these strains cause outbreaks in waterfowl. In this study, a reverse genetics system for highly virulent NDV isolated from goose flocks was developed independent of conventional T7 RNA polymerase. Infectious virus was successfully generated by an RNA polymerase II promoter to drive transcription of the full-length virus antigenome. A green fluorescent protein (GFP)-expressing virus was generated by inserting an additional transcription cassette coding for the enhanced GFP between the P and M genes of the genome. The expression of GFP was confirmed by western blotting and fluorescence microscopy. The replication kinetics and pathogenicity of the recombinant viruses are indistinguishable from the parental wild-type virus. This reverse genetics system will provide a powerful tool for the analysis of goose-origin NDV dissemination and pathogenesis, as well as preparation for genotype-matched NDV attenuated vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25384536     DOI: 10.1007/s11262-014-1137-x

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  17 in total

1.  Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation.

Authors:  S Krishnamurthy; Z Huang; S K Samal
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

2.  A goose-sourced paramyxovirus isolated from southern China.

Authors:  Chen Jinding; Liao Ming; Ren Tao; Xin Chaoan
Journal:  Avian Dis       Date:  2005-03       Impact factor: 1.577

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Genetic characterization and evolutionary analysis of 4 Newcastle disease virus isolate full genomes from waterbirds in South China during 2003-2007.

Authors:  Shaoxin Cai; Jun Li; Mabel Ting Wong; Peirong Jiao; Huiying Fan; Dawei Liu; Ming Liao; Jingwei Jiang; Mang Shi; Tommy Tsan-Yuk Lam; Tao Ren; Frederick Chi-Ching Leung
Journal:  Vet Microbiol       Date:  2011-04-22       Impact factor: 3.293

5.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence.

Authors:  B P Peeters; O S de Leeuw; G Koch; A L Gielkens
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Genome replication of Newcastle disease virus: involvement of the rule-of-six.

Authors:  B P Peeters; Y K Gruijthuijsen; O S de Leeuw; A L Gielkens
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

8.  Biological and phylogenetic characterization of a genotype VII Newcastle disease virus from Venezuela: efficacy of field vaccination.

Authors:  Francisco Perozo; Rosmar Marcano; Claudio L Afonso
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 9.  Newcastle disease: evolution of genotypes and the related diagnostic challenges.

Authors:  Patti J Miller; Eduardo Lucio Decanini; Claudio L Afonso
Journal:  Infect Genet Evol       Date:  2009-09-30       Impact factor: 3.342

10.  Infectious rabies viruses from cloned cDNA.

Authors:  M J Schnell; T Mebatsion; K K Conzelmann
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  8 in total

1.  An improved reverse genetics system for Newcastle disease virus genotype VII.

Authors:  Yuzhang Sun; Mingjun Sun; Yonglian Dai; Renfu Yin; Zhuang Ding
Journal:  Virol Sin       Date:  2016-12       Impact factor: 4.327

2.  Generation and evaluation of a genetically attenuated Newcastle disease virus rGM-VIIm as a genotype-matched vaccine.

Authors:  Minhua Sun; Bin Xiang; Yaling Li; Peng Xie; Shimin Gao; Yinfeng Kang; Pei Gao; Yanling Li; Zhaoxiong Wang; Jianpeng Liang; Deshui Yu; Tao Ren
Journal:  Virus Genes       Date:  2016-10-07       Impact factor: 2.332

Review 3.  Fluorescent and Bioluminescent Reporter Myxoviruses.

Authors:  Christina A Rostad; Michael C Currier; Martin L Moore
Journal:  Viruses       Date:  2016-08-04       Impact factor: 5.048

4.  Therapeutic targeting of liver cancer with a recombinant DNA vaccine containing the hemagglutinin-neuraminidase gene of Newcastle disease virus via apoptotic-dependent pathways.

Authors:  Li-Gang Chen; Yuan-Sheng Liu; Tang-Hui Zheng; Xu Chen; Ping Li; Chuan-Xing Xiao; Jian-Lin Ren
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

5.  Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings.

Authors:  Jianzhong Wang; Yanlong Cong; Renfu Yin; Na Feng; Songtao Yang; Xianzhu Xia; Yueqiang Xiao; Wenxiu Wang; Xiufan Liu; Shunlin Hu; Chan Ding; Shengqing Yu; Chunfeng Wang; Zhuang Ding
Journal:  Virus Res       Date:  2015-04-13       Impact factor: 3.303

6.  Cellular protein GLTSCR2: A valuable target for the development of broad-spectrum antivirals.

Authors:  Cui-Cui Li; Hui-Jun Dong; Peng Wang; Wen Meng; Xiao-Jing Chi; Shi-Chong Han; Shuo Ning; Chuang Wang; Xiao-Jia Wang
Journal:  Antiviral Res       Date:  2017-03-07       Impact factor: 5.970

7.  The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo.

Authors:  Hui-Jun Dong; Zhao-Hua Wang; Wen Meng; Cui-Cui Li; Yan-Xin Hu; Lei Zhou; Xiao-Jia Wang
Journal:  Viruses       Date:  2018-11-01       Impact factor: 5.048

Review 8.  Reverse Genetics for Peste des Petits Ruminants Virus: Current Status and Lessons to Learn from Other Non-segmented Negative-Sense RNA Viruses.

Authors:  Alfred Niyokwishimira; Yongxi Dou; Bang Qian; Prajapati Meera; Zhidong Zhang
Journal:  Virol Sin       Date:  2018-11-19       Impact factor: 4.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.